807 related articles for article (PubMed ID: 22345360)
1. Does the EQ-5D measure quality of life in schizophrenia?
Halling Hastrup L; Nordentoft M; Hjorthøj C; Gyrd-Hansen D
J Ment Health Policy Econ; 2011 Dec; 14(4):187-96. PubMed ID: 22345360
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis in severe mental illness: outcome measures selection.
Stant AD; Buskens E; Jenner JA; Wiersma D; TenVergert EM
J Ment Health Policy Econ; 2007 Jun; 10(2):101-8. PubMed ID: 17603150
[TBL] [Abstract][Full Text] [Related]
3. The EQ-5D in alcohol dependent patients: relationships among health-related quality of life, psychopathology and social functioning.
Günther O; Roick C; Angermeyer MC; König HH
Drug Alcohol Depend; 2007 Jan; 86(2-3):253-64. PubMed ID: 16930855
[TBL] [Abstract][Full Text] [Related]
4. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G
J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564
[TBL] [Abstract][Full Text] [Related]
5. Assessment of health state in patients with tinnitus: a comparison of the EQ-5D and HUI mark III.
Maes IH; Joore MA; Cima RF; Vlaeyen JW; Anteunis LJ
Ear Hear; 2011; 32(4):428-35. PubMed ID: 21221004
[TBL] [Abstract][Full Text] [Related]
6. Validity of the EQ-5D as a generic health outcome instrument in a heroin-dependent population.
van der Zanden BP; Dijkgraaf MG; Blanken P; de Borgie CA; van Ree JM; van den Brink W
Drug Alcohol Depend; 2006 Apr; 82(2):111-8. PubMed ID: 16168573
[TBL] [Abstract][Full Text] [Related]
7. The validity of EQ-5D US preference weights in liver transplant candidates and recipients.
Russell RT; Feurer ID; Wisawatapnimit P; Pinson CW
Liver Transpl; 2009 Jan; 15(1):88-95. PubMed ID: 19109831
[TBL] [Abstract][Full Text] [Related]
8. Preference-based quality of life in patients with Alzheimer's disease.
Karlawish JH; Zbrozek A; Kinosian B; Gregory A; Ferguson A; Glick HA
Alzheimers Dement; 2008 May; 4(3):193-202. PubMed ID: 18631968
[TBL] [Abstract][Full Text] [Related]
9. Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol.
Ariza-Ariza R; Hernández-Cruz B; Carmona L; Dolores Ruiz-Montesinos M; Ballina J; Navarro-Sarabia F;
Arthritis Rheum; 2006 Oct; 55(5):751-6. PubMed ID: 17013822
[TBL] [Abstract][Full Text] [Related]
10. Caregivers' assessments of preference-based quality of life in Alzheimer's disease.
Karlawish JH; Zbrozek A; Kinosian B; Gregory A; Ferguson A; Low DV; Glick HA
Alzheimers Dement; 2008 May; 4(3):203-11. PubMed ID: 18631969
[TBL] [Abstract][Full Text] [Related]
11. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus.
Aggarwal R; Wilke CT; Pickard AS; Vats V; Mikolaitis R; Fogg L; Block JA; Jolly M
J Rheumatol; 2009 Jun; 36(6):1209-16. PubMed ID: 19369452
[TBL] [Abstract][Full Text] [Related]
12. Danish EQ-5D population norms.
Sørensen J; Davidsen M; Gudex C; Pedersen KM; Brønnum-Hansen H
Scand J Public Health; 2009 Jul; 37(5):467-74. PubMed ID: 19535407
[TBL] [Abstract][Full Text] [Related]
13. Analysis of three outcome measures in moderate to severe psoriasis: a registry-based study of 2450 patients.
Norlin JM; Steen Carlsson K; Persson U; Schmitt-Egenolf M
Br J Dermatol; 2012 Apr; 166(4):797-802. PubMed ID: 22182212
[TBL] [Abstract][Full Text] [Related]
14. Patient-reported impact of urinary incontinence--results from treatment seeking women in 14 European countries.
Monz B; Pons ME; Hampel C; Hunskaar S; Quail D; Samsioe G; Sykes D; Wagg A; Papanicolaou S
Maturitas; 2005 Nov; 52 Suppl 2():S24-34. PubMed ID: 16297579
[TBL] [Abstract][Full Text] [Related]
15. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
Griebsch I; Coast J; Brown J
Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of EQ-5D in assessing health status in primary care patients with major depressive disorder.
Sapin C; Fantino B; Nowicki ML; Kind P
Health Qual Life Outcomes; 2004 May; 2():20. PubMed ID: 15128456
[TBL] [Abstract][Full Text] [Related]
17. [Discriminative ability, construct validity and sensitivity to change of the EQ-5D quality of life questionnaire in paranoid schizophrenia].
Konnopka A; Günther OH; Angermeyer MC; König HH
Psychiatr Prax; 2006 Oct; 33(7):330-6. PubMed ID: 17024582
[TBL] [Abstract][Full Text] [Related]
18. Clinicians' Views on Therapeutic Outcomes of Systemic Interventions and on the Ability of the EQ-5D to Capture these Outcomes.
Schawo SJ; Brouwer WBF; Hakkaart L
J Ment Health Policy Econ; 2017 Sep; 20(3):131-136. PubMed ID: 28869211
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
[TBL] [Abstract][Full Text] [Related]
20. [EuroQol-5D FOR quality of life assessment in cardiac rehabilitation].
Balestroni G; Omarini G; Omarini P; Zotti AM
G Ital Med Lav Ergon; 2007; 29(3 Suppl B):B56-62. PubMed ID: 18575359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
